Scott, Jan http://orcid.org/0000-0002-7203-8601
Grierson, Ashlee
Gehue, Lillian
Kallestad, Havard
MacMillan, Iain
Hickie, Ian
Article History
Received: 9 October 2018
Accepted: 24 December 2018
First Online: 17 January 2019
Compliance with ethical standards
:
: The study complies with the Declaration of Helsinki (the ethical approval and consent procedures are described in the text).
: All authors declare they have no links with Fitbit or Fitabase and that the research was undertaken without any input from these organizations. JS is a visiting professor at the Brain and Mind Centre at the University of Sydney. JS has received UK Grant funding from the Medical Research Council (including for projects on actigraphy and bipolar disorders) and from the Research for Patient Benefit programme (PB-PG-0609-16166: early identification and intervention in young people at risk of mood disorders). IBH is a Commissioner in Australia’s National Mental Health Commission; a Member of the Medical Advisory Panel for Medibank; a Board Member of Psychosis Australia Trust. IBH has received honoraria for presentations of his own work at educational seminars supported by a number of non-government organisations and by the pharmaceutical industry (including Servier, Pfizer, AstraZeneca and Eli Lilly). The University of Sydney (Principal Investigator: IH) received funding from Servier for a study of major depression and sleep disturbance in primary care settings. Other relevant funding for IBH in relation to this study includes NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders (APP 1061043) and ‘Testing and delivering early interventions for young people with depression’ (APP 1046899).